$1.32
+0.76%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.34
From 52W high−52.52%
Volume136877.00
Market cap$62.19M
P/E (TTM)—
P/S (TTM)5.4x
Div yield—
Key dataOct 19, 2026
Open
$1.34
From 52W high
−52.52%
Volume
136877.00
Market cap
$62.19M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.0x
P/E (TTM)
—
RSI (14)
46.3
MomentumView details →
1D Return
+0.76%
YTD Return
−26.92%
Similar companies
Latest newsMore news →
MindWalk Holdings Corp. announced three senior appointments to strengthen its Boston-based development leadership, including Zachary Maben as Director of Antigen Discovery & Protein Engineering and Joanne Lim as Director of Preclinical Development.6d agoMindWalk Holdings Corp. reported a Q1 loss of $0.09 per share, missing the Zacks Consensus Estimate of a $0.05 loss and wider than the $0.07 loss a year earlier, with revenue also below estimates.35d agoMindWalk Holdings Corp. reported fiscal 2027 first-quarter results for the quarter ended July 31, 2026, with revenue up 21.3% year over year to $3.8 million and gross margin expanding to 58.6% from 48.3%.35d ago